You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (8)

Journals (0)

1-8 of 8 results for alectinib clinical trials

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases

Open access

Review article

First published 2019

Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases

Pascale Tomasini, Julie Egea, Maxime Souquet-Bressand [...]

Therapeutic Advances in Respiratory Disease

Select article: Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties,efficacy,safety and place in therapy

Open access

Review article

First published 2018

Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties,efficacy,safety and place in therapy

Tiziana Vavalà, Silvia Novello

Therapeutic Advances in Medical Oncology

Select article: Cost-effectiveness analysis of alectinib versus crizotinib in first-line treatment of anaplastic lymphoma kinase-positive advanced non-small cell lung cancer

Open access

Research article

First published 2019

Cost-effectiveness analysis of alectinib versus crizotinib in first-line treatment of anaplastic lymphoma kinase-positive advanced non-small cell lung cancer

Ravasio R, Tiseo M, Pradelli L [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Select article: Alectinib continuation during COVID 19 ‘antiviral’ treatment: Risk or benefit?

Retricted access

Case report

First published 2021-7

Alectinib continuation during COVID 19 ‘antiviral’ treatment: Risk or benefit?

Mehmet Hadi Akkus, Omur Kaman, Mutlu Dogan

Journal of Oncology Pharmacy Practice

Select article: First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis

Open access

Research article

First published 2022-11

First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis

Jiahao Tao, Chuangjie Zheng, Cuifen Zhang [...]

Journal of International Medical Research

Select article: Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis

Open access

Research article

First published 2022

Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis

Yaokai Wen, Tao Jiang, Xiangrong Wu [...]

Therapeutic Advances in Medical Oncology

Select article: Cost-Effectiveness Analysis of 6 Tyrosine Kinase Inhibitors as First-Line Treatment for ALK-Positive NSCLC in China

Open access

Research article

First published 2024

Cost-Effectiveness Analysis of 6 Tyrosine Kinase Inhibitors as First-Line Treatment for ALK-Positive NSCLC in China

Meiling Zhang, Bei Zheng, Wenjuan Yang [...]

Clinical Medicine Insights: Oncology

Select article: Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches

Free access

Review article

First published 2016-4

Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches

Meghan Shea, Daniel B. Costa, Deepa Rangachari

Therapeutic Advances in Respiratory Disease

1
10 / page

Article type

Publication date

Subjects

Access